MENU
LPCN
Stock ticker: NASDAQ
PRICE
CHANGE
CAPITALIZATION

Lipocine (LPCN) Ownership - Who owns Lipocine?

Lipocine Inc is a clinical-stage biopharmaceutical company that is engaged in research and development for the delivery of drugs using its proprietary delivery technology... Show more

Profile

Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
14
Web
https://www.lipocine.com

Details

Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
18.88M
P/E Ratio
N/A
Total Cash
24.73M
Projected Growth
N/A
Total Debt
1.48M
Revenue
2M
Risk (Beta)
-0.62
Dividend Yield
N/A
Total Cash/Share
3.00
Total Debt/Equity
N/A
Revenue/Share
0.33 USD as % of share price
View a ticker or compare two or three
LPCN
Daily Signal:
Gain/Loss:
Interact to see
Advertisement
A.I.Advisor
published price charts
Last 5 trading days
A.I. Advisor
published General Information

General Information

a developer of pharmaceutical products

Industry Biotechnology

Profile
Details
Industry
Pharmaceuticals Other
Address
675 Arapeen Drive
Phone
+1 801 994-7383
Employees
14
Web
https://www.lipocine.com